Get started
Author

Carolina Méndez‐Blanco

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
2018 · Carolina Méndez-Blanco, Flavia Fondevila, et al. · Experimental & Molecular Medicine · 349
PDF
Melatonin‐induced increase in sensitivity of human hepatocellular carcinoma cells to sorafenib is associated with reactive oxygen species production and mitophagy
2016 · Néstor Prieto‐Domínguez, Raquel Ordóñez, et al. · Journal of Pineal Research · 140
Antitumor Effects of Quercetin in Hepatocarcinoma In Vitro and In Vivo Models: A Systematic Review
2019 · Paula Fernández-Palanca, Flavia Fondevila, et al. · Nutrients · 95
PDF
Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
2019 · Flavia Fondevila, Carolina Méndez-Blanco, et al. · Experimental & Molecular Medicine · 87
PDF
Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy
2017 · Néstor Prieto-Domínguez, Carolina Méndez-Blanco, et al. · Oncotarget · 80
PDF
Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review
2021 · Paula Fernández-Palanca, Carolina Méndez-Blanco, et al. · Antioxidants · 52
PDF
Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells
2019 · Carolina Méndez-Blanco, Flavia Fondevila, et al. · Cancers · 45
PDF
Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation
2022 · Paula Fernández-Palanca, Tania Payo-Serafín, et al. · Acta Pharmacologica Sinica · 36
Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis
2021 · Flavia Fondevila, Paula Fernández-Palanca, et al. · Cancers · 27
PDF
Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis
2021 · Carolina Méndez-Blanco, Paula Fernández-Palanca, et al. · Therapeutic Advances in Medical Oncology · 22
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies
2022 · Paula Fernández-Palanca, Tania Payo-Serafín, et al. · Cancers · 20
PDF
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
2023 · Paula Fernández-Palanca, Tania Payo-Serafín, et al. · Clinical and Molecular Hepatology · 17
PDF
Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib
2021 · Flavia Fondevila, Carolina Méndez-Blanco, et al. · International Journal of Molecular Sciences · 16
PDF
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
2024 · Tania Payo‐Serafín, Carolina Méndez‐Blanco, et al. · Clinical Pharmacology & Therapeutics · 9
PDF
SAT-112 Role of hypoxia on the progression and survival of hepatocellular carcinoma in hypoxia-inducible factor 1 alpha knockout bi- and tri-dimensional in vitro models
2025 · Tania Payo-Serafín, Jennifer Martínez-Geijo, et al. · Journal of Hepatology · 1
Correction: Fondevila et al. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 2021, 13, 5349
2025 · Flavia Fondevila, Paula Fernández-Palanca, et al. · Cancers · 1
PDF
Reels, Stories and Biology in Service-learning Projects: the “biometac Caravan” Experience
2026 · Rayo Pinto, Laura Álvarez-Fernández, et al. · EDULEARN proceedings
Impeding hypoxia-driven tumor progression in hepatocellular carcinoma: clinical and pre-clinical analyses using 2D and 3D in vitro models
2026 · Tania Payo-Serafín, Carolina Méndez-Blanco, et al. · Biology Direct
25 - Hipoxia En El Carcinoma Hepatocelular Humano: Identificación De Genes De Expresión Diferencial Mediante Análisis Bioinformático
2026 · Jennifer Martínez-Geijo, Tania Payo-Serafín, et al. · Gastroenterología y Hepatología
5 - Bloqueo Del Factor Inducible Por Hipoxia 1? Como Adyuvante a La Terapia Con Inhibidores Tirosina Quinasa En El Hepatocarcinoma
2026 · Tania Payo-Serafín, Jennifer Martínez-Geijo, et al. · Gastroenterología y Hepatología
200P Targeting hypoxia-inducible factor 1α to suppress hypoxia-mediated progression and invasion of hepatocellular carcinoma
2025 · T. Payo-Serafín, J. Martínez-Geijo, et al. · Annals of Oncology
PDF
201P Exploring differentially expressed genes associated with HIF1A and tumor proliferation in hepatocellular carcinoma: Bioinformatics and in vivo study
2025 · J. Martínez-Geijo, T. Payo-Serafín, et al. · Annals of Oncology
PDF
WED-115 Differential gene expression in hepatocellular carcinoma: a bioinformatic approach to correlate with HIF1A
2025 · Jennifer Martínez-Geijo, Tania Payo-Serafín, et al. · Journal of Hepatology
180P A systematic review with meta-analysis of risks and benefits of tyrosine kinase inhibitors in hepatocellular carcinoma treatment
2024 · J. Martínez-Geijo, T. Payo-Serafín, et al. · Annals of Oncology
PDF
Correction: Méndez-Blanco et al. Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells. Cancers 2019, 11, 1984
2023 · Carolina Méndez-Blanco, Flavia Fondevila, et al. · Cancers
PDF
Works count: 27
Citation count: 997
H-index: 13
I10-index: 13
Year
Topic
Type